Durvalumab plus tremelimumab in biologically selected advanced/metastatic solid tumors-MedSci.cn

Durvalumab plus tremelimumab in biologically selected advanced/metastatic solid tumors

De la Fouchardiere, C; Gomez-Roca, CA; De Montfort, A; Italiano, A; Gilabert, M; Tredan, O; Korakis, IN; Ray-Coquard, IL; Rochefort, P; Dufresne, A; Cousin, S; Le Tourneau, C; You, B; Bertucci, F; Cassier, PA; Attignon, VPR; Mayet, R; Garin, G; Perol, D; Blay, JY